You searched for "correction"

2931 results found

Effect of blue-light filtering intraocular lenses on age-related macular degeneration

This is a retrospective cohort study evaluating whether blue-light filtering (BLF) intraocular lenses (IOL) offer prophylaxis for neovascular age-related macular degeneration (nAMD). The study included 11,397 eyes of 11,397 patients with a mean age of 75.4 ±8.3 years that underwent...

Sequential scleral fixated IOL followed by DSAEK better than simultaneous approach

This prospective randomised comparative study compared a simultaneous approach of combined scleral-fixated intraocular lens (SF IOL) and Descemet-stripping automated endothelial keratoplasty (DSAEK) compared to intrascleral haptic fixation technique, followed by DSAEK in a sequential fashion with an interval of at...

Complications after cataract surgery in high myopes: a systematic review and meta-analysis

The authors review all the modern literature on complications after phacoemulsification in high myopes with axial lengths (AL) greater than 25.0mm. Twenty-eight studies reporting on 19,586 eyes were included. The corrected distance visual acuity (CDVA) improved from 0.96 ± 0.53...

RCT of VR training versus occlusion for amblyopia

The purpose of this study was to compare the visual outcomes of occlusion with game playing through a virtual reality (VR) system in children with unilateral amblyopia. The study was undertaken at the Negah Eye Hospital in Iran. This was...

Aflibercept (AF) for age-related macular degeneration (ARMD): four-year outcomes of a ‘’treat-and-extend’ (T&E) regimen with exit-strategy

This is a retrospective observational study of 82 patients, between 2014 to 2016 from Switzerland of treatment-naive patients with nARMD, treated with AF, with specific T&E protocol without a loading phase and predefined exit criteria and patients were observed three...

Chorioretinal atrophy in punctate inner choroidopathy / multifocal choroiditis

This study reported the five-year outcomes of chorioretinal atrophy (CRA) progression in patients with punctate inner choroidopathy (PIC) or multifocal choroiditis (MFC) in 45 eyes of 36 patients. The mean age of the cohort of patients was 37 ±13.37 years...

Silicone oil (SOT) versus gas (GT) tamponade for primary rhegmatogenous retinal detachment treated successfully with a propensity score analysis

This is a retrospective, nationwide, multicentre study with retinal detachment (RD) in the Japan-RD Registry between 2016 to 2017. The primary outcome was the estimated mean difference of postoperative cerebral vascular accident (CVA) in six months and a propensity score...

Outcomes of chemo versus no therapy for optic pathway glioma in NF1

The aim of this study was to evaluate the visual outcomes of a cohort of children with optic pathway gliomas and neurofibromatosis type 1 (NF1), with comparison of children treated with chemotherapy or not. This was a retrospective study of...

Two-year results of a T&E aflibercept regime in caucasian PNV

This a retrospective study examining two-year outcomes of patients with pachychoroid neovasculopathy (PNV) treated with a treat and extend (T&E) regimen of intravitreal aflibercept. The mean age was 63.84 ± 7.92 years with nine males (35%) and 17 females (65%)....

Brolucizumab in age-related macular degeneration, HAWK Study

The aim of the study was to collect additional data on efficacy and safety of brolucizumab 6mg intended for commercialization in age-related macular degeneration (AMD) (with an increase in pH and decrease in polysorbate concentration). The HAWK Study was a...

Ocular motility parameters in phakic and pseudophakic older people

The aim of this study was to compare the extent of phoria, strabismus and convergence of pseudophakic vs phakic people in an elderly population. The study was part of the Tehran Geriatric Eye Study (TGES). Of 3791 invitees, 3310 participated...

Bromfenac versus betamethasone in diabetic macular oedema

This is a randomised, prospective, single-centre trial in patients diagnosed with diabetic macular oedema (DMO) with central subfield thickness (CST) of 250-500µm, who refused anti-VEGF treatment. Nineteen eyes of 19 patients were randomised to bromfenac (BF) or betamethasone (BM) drops,...